OSR Health annual ebitda
2023
2024
2025
OSR Health EBITDA Growth & History (OSRH)
OSR Health's calculated EBITDA was −$9.0M for fiscal 2025.
View full OSR Health company overviewOSR Health annual ebitda history
| Fiscal year | Period ended | EBITDA | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | −$9.0M | −$7.0M | — |
| 2024 | 2024-12-31 | −$2.1M | −$3.0M | — |
| 2023 | 2023-12-31 | $944,591 | — | — |
OSR Health quarterly ebitda
Q1.24
Q3.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | EBITDA | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | −$669,972.94 | $2.2M | — |
| Q1 2026 | 2026-03-31 | −$1.2M | −$596,793.19 | — |
| Q4 2025 | 2025-12-31 | −$4.1M | — | — |
| Q3 2025 | 2025-09-30 | −$1.4M | −$709,994 | — |
| Q2 2025 | 2025-06-30 | −$2.9M | — | — |
| Q1 2025 | 2025-03-31 | −$644,631.4 | −$255,213.4 | — |
| Q3 2024 | 2024-09-30 | −$706,725 | — | — |
| Q1 2024 | 2024-03-31 | −$389,418 | — | — |
OSR Health ebitda trends
Between the periods ended 2023-12-31 and 2025-12-31, OSR Health's ebitda decreased from $944,591 to −$9.0M, a change of −$10.0M. The latest reported quarter, Q2 2026, shows −$669,972.94.
About the metric
What EBITDA means
EBITDA is a measure of operating performance before interest, taxes, depreciation, and amortization. It can help compare operating results, but it is not a substitute for cash flow or GAAP net income.
Calculation and source
How TickerStat calculates EBITDA
TickerStat calculates EBITDA as operating income plus reported depreciation and amortization for aligned fiscal periods. It is calculated data, not adjusted EBITDA or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review OSR Health source filings ↗